Showing results (1-10 of 718) with videos related to
Sort By:
Pageof 72
European Journal of Haematology|January 27, 2007
Reduced-intensity allogeneic transplantation in patients with refractory or progressive Hodgkin's disease after high-dose chemotherapy and autologous stem cell infusionElisabetta Todisco, Luca Castagna, Barbara Sarina, et al.Leukemia & Lymphoma|January 7, 2009
Early discharge after high-dose melphalan and peripheral blood stem cell reinfusion in patients with hematological and non-hematological diseaseAntonella Anastasia, Fabio Giglio, Rita Mazza, et al.American Journal of Hematology|October 5, 2006
Tandem high-dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: a monocenter prospective studyLuca Castagna, Massimo Magagnoli, Monica Balzarotti, et al.European Journal of Haematology|February 23, 2007
CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patientsElisabetta Todisco, Luca Castagna, Barbara Sarina, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 17, 2009
Allogeneic stem cell transplantation compared with chemotherapy for poor-risk Hodgkin lymphomaLuca Castagna, Barbara Sarina, Elisabetta Todisco, et al.British Journal of Haematology|April 7, 2009
Predictive value of early 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) during salvage chemotherapy in relapsing/refractory Hodgkin lymphoma (HL) treated with high-dose chemotherapyLuca Castagna, Stefania Bramanti, Monica Balzarotti, et al.Journal of Blood Medicine|November 5, 2020
Salvage Therapy for Hodgkin's Lymphoma: A Review of Current Regimens and OutcomesLuca Castagna, Armando Santoro, Carmelo Carlo-StellaJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2003
Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy?Giovanna Masci, Massimo Magagnoli, Paolo Andrea Zucali, et al.American Journal of Hematology|July 25, 2003
Feasibility and toxicity of high-dose therapy (HDT) supported by peripheral blood stem cells in elderly patients with multiple myeloma and non-Hodgkin's lymphoma: survey from a single institutionMassimo Magagnoli, Luca Castagna, Monica Balzarotti, et al.Journal of Clinical Medicine|November 11, 2020
Haploidentical Stem Cell Transplantation in Lymphomas-Expectations and PitfallsJacopo Mariotti, Stefania Bramanti, Armando Santoro, et al.Pageof 72